Inhaled Insulin: Quick Reference Sheet for Healthcare Providers

Afrezza® is the only FDA-approved inhaled insulin for adults with diabetes, offering ultra-rapid absorption through the lungs to better mimic physiologic insulin and eliminate the need for pre-bolusing. Clinical studies show it is as effective as injections for lowering A1C, with similar safety, while providing a faster onset and shorter duration of action—making it a practical option for mealtime or correction dosing. Download our Quick Reference for Healthcare Providers to learn when to consider Afrezza, dosing guidance, and safety monitoring recommendations.